cancer treatment

how Hyperbaric therapy can help 

HBOT has been shown in some studies to: Enhance "Conventional" Cancer Therapies & Treatments, Reduce Tumor Aggressiveness, Increase Natural Killer Cell, Activity & Function, Reduce Side Effects of Conventional Cancer Therapies Treatments, Enhance IV Cancer Treatments, and Cancer Prevention

In 2013, over 1.6 million people were diagnosed with cancer and over 500,000 cancer-related deaths occurred in the U.S. alone. Cancer is one of the leading causes of death, world-wide, and new integrated treatments are being utilized to help combat its devastating effects. Hyperbaric oxygen therapy (HBOT) is currently being utilized in conjunction with conventional treatments, including radiation and chemotherapy, to attain optimal dosages for patients, stimulate tumor regression and reduce the side effects of treatments. Cancer thrives in hypoxic or low-oxygen environments and HBOT has been shown to increase these oxygen levels to weaken tumors and reduce their aggressiveness. Studies have demonstrated the benefits of HBOT for cancer with the following:

Enhance “Conventional” Cancer Therapies & Treatments

  • Reduces Tumor Hypoxia
  • Better Radiation Therapy ResultsImproves Chemotherapy OutcomeEnhances Glioblastoma Treatment
  • Decreases Tumor Drug Resistance Allows for Optimal Therapy Dosage to be Attained
  • Increases Post-Op Fibroblast Activation

Reduce Side Effects of “Conventional” Cancer Therapies & Treatments

Reduces radiation therapy side effects, decreases chemotherapy side effects, accelerates post-operative healing & prevents infection, reduces chemo-brain syndrome symptoms. 

Reduce Tumor Aggressiveness

  • Weakens hypoxic tumors
  • Targets metastatic tumors

Increase Natural Killer Cell Activity and Function 

  • Increases reactive oxygen species production 
  • Amplifies cancer cell death 
  • Regresses tumor volume

Enhance IV Cancer Treatments with HBOT  

  • Increases Intravenous Vitamin C Therapy Effect


  • Reduces Radiation Therapy Side Effects
  • Accelerates Post-Operative Healing & Prevents Infection
  • Decreases Chemotherapy Side Effects
  • Reduces Chemo-Brain Syndrome Symptoms

Cancer Prevention

  • Decreases inflammatory markers
  • Normalizes intracellular oxygen levels
  • Stimulates cellular detoxification
  • Reduces risk of pathogenic inflammatory-related tumors
  • Supports cellular energy processes for optimal DNA repair


Tumor Regression Stimulated by HBOT

A non-randomized trial was conducted with 29 patients to evaluate the effectiveness of radiotherapy combined with HBOT, in patients with a malignant tumor. Fifteen patients were irradiated daily after HBOT and fourteen other irradiated patients were treated without HBOT. In the HBOT group, 11 of 15 patients (73 percent) showed greater than 50 percent tumor regression. In the non-HBOT group, only four of 14 patients (29 percent) underwent tumor regression. The average survival rate in patients with HBOT doubled that of the non-HBOT group (24 months vs. 12 months) respectively. No serious side-effects were observed in the HBOT patients. This provides additional support for HBOT to be a beneficial treatment for malignant tumors.


The information presented on this website is not intended as a basis for diagnosis or treatment and does not constitute a medical recommendation for individual health conditions. Content should also not be considered a substitute for care under a licensed medical professional. OBISPO HYPERBARIC supports the FDA for your full informed consent.

Start HEALING today!